Z-16-b

N/A

Report date: 2026/01/19 17:49:24
NME

Base Information

Drug NameZ-16-b
Drug Alias NameZ-16bZ-16-b
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRyanodine receptor 2 modulators
TargetsRyanodine receptor 2
Therapy Area/IndicationsTachycardia, Ventricular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen University
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen University
Inactive CompaniesN/A
Active IndicationsTachycardia, Ventricular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A